Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us  
Google
Web www.equitybulls.com
Stock Report

| More

Laurus Labs enters the rapidly growing biotechnology segment by acquiring a majority stake in Richcore Lifesciences

Posted On: 2020-11-25 05:31:19 (Time Zone: Arizona, USA)


Laurus Labs Ltd. (Laurus BSE: 540222, NSE: Lauruslabs, ISIN: INE947Q01028) has signed a definitive agreement to acquire a majority stake in Richcore Lifesciences Pvt Ltd (Richcore). Richcore, a fast-growing biotech company based in Bengaluru with its advanced R&D and manufacturing facilities, develops and manufactures biotech products critical for manufacturing biological drugs. Richcore also helps its global customers to develop and scale-up their bioprocesses by providing contract research, development, and manufacturing services.

This acquisition marks Laurus Labs' entry into the broader biologics and biotechnology segments, providing the company access to its high growth areas, globally and in India. Laurus Labs will help and drive Richcore to achieve scale and improve product offerings. With this acquisition, Laurus adds a fourth revenue stream to its three existing divisions - API, Formulations and Synthesis. Following the successful closure of the transaction, Richcore will be renamed to Laurus Bio Pvt Ltd.

Richcore has large scale fermentation capabilities and manufactures animal origin free (AOF) recombinant products. These products help vaccine, insulin, stem-cell based regenerative medicine and other biopharma companies eliminate dependency on animal and human blood derived products and in turn produce safer medicines. Richcore is currently in its growth phase and its second manufacturing plant near Bengaluru is expected to be completed by 31 March 2021. Richcore has raised early and growth stage funding from Eight Roads Ventures, VenturEast Proactive Fund and VenturEast Life Fund III.

Laurus Labs has signed a definitive agreement to acquire 72.55% of Richcore's shares from Eight Roads Ventures and VenturEast for a value of Rs. 246.7 crores. The current promoters of Richcore led by Mr. Subramani Ramachandrappa will continue as promoters of Richcore and will be responsible for its management and operations. Laurus Labs will fund the acquisition from its internal accruals and this acquisition will be revenue and PAT accretive.

Commenting on the development, CEO of Laurus Labs Dr. Satyanarayana Chava said, "we are very excited on this acquisition, as this gives us entry into high barrier biotechnology segment. Laurus Labs will bring scale to Richcore' s operations and can become a major player in the biotech CDMO space . This will also help Laurus in becoming a leader in biocatalysis as Richcore brings significant expertise in enzyme development for pharmaceutical and other industrial applications."

Subramani Ramchandrappa, Chairman & Managing Director, Richcore Lifesciences said, "Richcore and Laurus Labs coming together marks the convergence of Biotechnology and Chemistry faculties. Leveraging the synergies arising from Laurus's experience and Richcore's innovation, we plan to build scale as we continue to serve our existing customers and enter new biotech segments. We welcome Laurus Labs on board and thank our customers and team members for their continued patronage and trust in our shared vision. We also thank our existing investors Eight Roads Ventures and VenturEast for their support since our inception."

Dr. Prem Pavoor, Partner & Head of India, Eight Roads Ventures said: "We are very excited and proud to see two of our partner companies come together to create the beginnings of a global lifesciences leader. There has been a distinct upsurge in demand for biologics and vaccine manufacturing as well as a move away from animal-derived biologic products over the past few years, and now accelerated by the Covid-19 pandemic. Richcore's capabilities in biologic development and manufacturing are synergistic with Laurus' track record of building global leadership and world-class manufacturing scale in important therapeutic categories. The combination of Dr. Satya and Subbu's leadership will definitely create a strong biopharmaceuticals development and manufacturing organisation."

Dr. Siddhartha Das, General Partner, VenturEast said: "Richcore is an innovation driven Biotechnology Company charting an exciting journey into new technologies with the potential to revolutionize areas of human health, food security and sustainability. The strategic partnership with Laurus Labs will create a strong platform for both innovation and rapid scaling."

Sarath Naru, Managing Partner, VenturEast, said: "Richcore's Leadership has shown the tenacity and vision to create a high barrier complex "Animal Origin Free" category in the biotech space. We backed the founder and his team early on from the first round until the latest Series C round. We are extremely proud to have backed this pioneering team in a category that will grow multifold in the coming decade."

Shares of Laurus Labs Ltd was last trading in BSE at Rs.285.05 as compared to the previous close of Rs. 289.75. The total number of shares traded during the day was 191513 in over 6743 trades.

The stock hit an intraday high of Rs. 292.3 and intraday low of 282.05. The net turnover during the day was Rs. 54797399.


Source: Equity Bulls

Click here to send ur comments or to feedback@equitybulls.com





Other Headlines:

Ind-Ra upgrades Happiest Minds Technologies Limited's Long-Term Issuer Rating

Brickwork reaffirms Dhanlaxmi Bank's rating of Lower Tier-II bonds - Series XV

AGEL commissions 100 MW Gujarat Wind Power Project 5 months before schedule

Meera Industries Limited receives order of $180,000

Atul Auto launches its all new Nxt Gen, Atul RIK CNG Autorickshaw for Gujarat

NATCO receives final approval for Everolimus tablets for the US market

Blue Star declared winner of the prestigious 'Golden Peacock Award for Excellence in Corporate Governance' for 2020

Just Dial enters into an advertisement agreement for IPL

Fortis Hospital, Faridabad extends it services at Mathura, Launches Super Specialty OPD services

Fire accident at Radico Khaitan Ltd's Rampur plant

Adani Ports and SEZ Limited to allot 1 crore shares to Windy Lakeside Invesment Ltd

Hero MotoCorp Limited announces exclusive offer for women riders

Mayukh Dealtrade Ltd board to consider Stock Split of Equity Shares

CARE downgrades ratings of Srei Infrastructure Finance Limited to default category

Shish Industries Limited forms subsidiary

Dhani Services Limited board approves sponsored Level III ADR

Prakash Steelage Ltd board approves sale of shares of Tubacex Prakash India Pvt Ltd

Sayaji Hotels Management Ltd enters into management agreement for 7 properties

GRSE Lays Keel of 3rd Ship of Prestigious Project 17A Advanced Stealth Frigate

NMDC revises prices of iron ore w.e.f. 06-03-2021

Aarti Speciality Chemicals Limited receives an approval accorded under PLI Scheme for Pharmaceutical Sector

Mawana Sugars Limited approves investment of Rs. 10 crores in Siel Industrial Estate Ltd

TVS Motor Company to provide free COVID-19 vaccination to all employees and their immediate family members

Satyam Silk Mills Ltd board to consider rights issue on March 10, 2021

GRM Overseas Ltd board to consider interim dividend on March 10, 2021

Rushil Decor Limited starts commercial production of MDF board at new Vizag plant

IIFL Securities Ltd board to consider interim dividend on March 10, 2021

DCW Limited allots debentures to Kotak Special Situations Fund

M G George Muthoot, Chairman of Muthoot Finance Limited passes away

Acuite Ratings & Research Limited update on rating of Edelweiss Financial Services Limited

Kotak Mahindra Bank Appoints Dr Ashok Gulati as an Additional Independent Director on its Board

Xanadu Realty ties up with Poddar Housing Development Limited in a mega portfolio deal

Edelweiss Financial Services Limited updates on credit rating of proposed NCD issue

IndiGrid signs the largest power transmission deal with Sterlite Power AUM to leapfrog to over INR 200 Bn

Indian Bank to divest stake in JV, ASREC India Ltd

Dai-ichi Karkaria Limited updates on Kasarwadi Land Deal

AKI India Ltd approves construction of effluent treatment plant

Kotak Silk Launches Eduseries for Financial Independence of Women

Ind-Ra has assigned ratings to JSW Hydro Energy Ltd

Shriram EPC Limited board to consider issue of preference shares to lenders

Suncare Traders Limited to demerge investment division to Madhav Infra Projects Ltd

Astral Poly Technik Limited fixes March 19, 2021 as record date for bonus issue

Mazagon Dock Shipbuilders Limited gifts refrigerated truck

Sandhar Technologies Ltd announces incorporation of step down subsidiary

NMDC LTD. board to consider interim dividend on Mar 11, 2021

CRISIL revises outlook of Canara Bank's long-term debt instruments

Hero MotoCorp launches 4-day special service and exchange carnival

ICICI Lombard General Insurance Company Limited board approves interim dividend of Rs. 4

Sun Pharma arm to acquire stake in WRS Bioproducts Pty Ltd, Australia

Kirloskar Oil Engines Ltd declares interim dividend of Rs. 1.50 for FY21



Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2020